The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2023
DOI: 10.3389/fmed.2023.1238333
|View full text |Cite
|
Sign up to set email alerts
|

An exploratory study of unexplained concentration of 18F-PSMA-1007 in the bladder for prostate cancer PET/CT imaging

Jun Dang,
Yutang Yao,
Yingchun Li
et al.

Abstract: 18F-PSMA-1007 PET/CT imaging is increasingly used for the diagnosis, staging, and efficacy assessment of patients with prostate cancer. Compared with other PSMA tracers, 18F-PSMA-1007 is mainly cleared by the liver and bile and has lower urinary clearance, thus allowing a better assessment of the lesions around the bladder. However, there were some patients who showed an obvious concentration of the 18F-PSMA-1007 in the bladder, which may affect the observation of peripheral lesions, but the mechanism of this … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 26 publications
0
1
0
Order By: Relevance
“…In contrast, other studies investigated poor correlations between renal [ 18 F]PSMA-1007 uptake and eGFR [37]. Moreover, the [ 18 F]PSMA-1007 uptake within the bladder also showed no correlation with kidney function [38]. Several efforts have been made to reduce renal uptake, either to improve the tumor-to-kidney ratio and, thus, a sensitivity for renal or kidney-adjacent tumors by evaluating new radiopharmaceuticals [39] or for dosimetric purposes by administering additional drugs in preparation [40].…”
Section: Results and Comparison To The Literaturementioning
confidence: 91%
“…In contrast, other studies investigated poor correlations between renal [ 18 F]PSMA-1007 uptake and eGFR [37]. Moreover, the [ 18 F]PSMA-1007 uptake within the bladder also showed no correlation with kidney function [38]. Several efforts have been made to reduce renal uptake, either to improve the tumor-to-kidney ratio and, thus, a sensitivity for renal or kidney-adjacent tumors by evaluating new radiopharmaceuticals [39] or for dosimetric purposes by administering additional drugs in preparation [40].…”
Section: Results and Comparison To The Literaturementioning
confidence: 91%